Expression of the tumour suppressor genes p15 and p16 in malignant melanoma

Melanoma Research

Volumn 6, Issue 4, 1996, Pages 285-289

  Robinson, W A ^a,c   Elefanty, A G ^a   Hersey, P ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Expression; Melanoma; p15; p16; Tumour suppressor genes

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA; MOLECULAR BIOLOGY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029838972     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199608000-00002     Document Type: Article

References (20)

1. Coleman A, Fountain, JW, Nobori T, et al. Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res 1994; 54: 344-348.
2. Fountain JW, Karayiorgou M, Ernstoff MS, et al. Homozygous deletions of human chromosome 9p21 in melanoma. Proc Natl Acad Sci USA 1992; 89: 10557-10561.
3. Kamb A, Gruis, NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
4. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707.
5. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature 1994; 371: 257-262.
6. Guan K-L, Jenkins CW, Li Y, et al. Growth suppression by p18, a p16 and p14 related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 1993; 8: 2939.
7. Hirama T, Koeffler HP. Role of the cyclin-dependent kinases inhibitors in the development of cancer. Blood 1995; 86: 841-854.
8. INK4 gene mediated by an adenovirus vector. Cancer Res 1994; 55: 3250-3253.
9. Mori T, Miura K, Aoki T, et al. Frequent somatic mutation of the MTSl/CDK4I (multiple tumor suppressor/cyclin-dependent kinases 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994; 54: 3396-3397.
10. Caldas C, Hahn SA, da Costa LT, et al. Frequent somatic mutations and homozygous deletions of the P16 adenocarcinoma. Nature Genet 1994; 8: 27-32.
11. Liu Q, Neuhausen S, McClure M, et al. CDKN2 (MTSl) tumor suppressor gene mutations in human tumor cell lines. Oncogene 1995; 10: 1061-1067.
12. ink4 gene inactivation in acute lymphocytic leukemia. Blood 1995; 85: 3431-3436.
13. Sill H, Goldman JM, Cross NCP. Homozygous deletions of the tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 1995; 85: 2013-2016.
14. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nature Genet 1994; 8: 15-21.
15. Kamb A, Shattuck-Eidens D, Eeles R, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 1994; 8: 22-26.
16. Ohta M, Nagai H, Shimizu M, et al. Rarity of somatic and germline mutations of the cyclin-dependent kinases 4 inhibitor gene, cdk4i, in melanoma. Cancer Research, 54: 5269-5272; 1994.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
18. Greenblatt M, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878.
19. Gruis NA, Weaver-Feldhaus J, Liu Q, et al. Genetic evidence in melanoma and bladder cancer that p16 and p53 function in separate pathways of tumor suppression. Am J Pathol 1995; 146: 1199-1206.
20. ink4/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis. Oncogene 1995; 11: 1399-1402.